See also: Clinical Trial
NCT00605215 is a multinational, randomized, parallel-group study performed in subjects with RRMS to assess the efficacy, safety and tolerability of laquinimod over placebo in a double-blind design and a reference arm of interferon β-1a. Other study IDs include: MS-LAQ-302, EUDRACT 2007-005450-23.
|This item is relevant to you: Participate in clinical trial||1||0||
- Can't tell